Brinton Pharmaceuticals Limited, a active public limited company, was established on 27 September 2013 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232PN2013PLC148971. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.09 Cr.
It upholds a compliant status. Employing 508 professional, Its leadership includes Rahul Kundanmal Darda (Managing Director), Ronak Hemprakash Shah (Director), Chaitali Rahul Darda (Director). Past directors included Bonnie Ann Marie Weekes, Rahul Kundanmal Darda, Kerry Donald Bell. It holds ₹75.25 Cr open charges and ₹81.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S. No 55/2 Kharadi, Taluka Haveli, Pune, Maharashtra, 411014.
U24232PN2013PLC148971
148971
27 September 2013
₹2.00 Cr
₹1.09 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Brinton Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Kundanmal Darda | Managing Director | 27 Sep 2013 | Current |
| Ronak Hemprakash Shah | Director | 28 Mar 2024 | Current |
| Chaitali Rahul Darda | Director | 27 Sep 2013 | Current |
| Shivani Bhasin | Nominee Director | 13 Jun 2019 | Current |
| Visalakshi Chandramouli | Nominee Director | 30 Mar 2017 | Current |
| Sudeep Chhallani | Director | 28 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 03 Sep 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 31 Aug 2015 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 13 Jun 2019 | Past |
| Pramod Abcsdd | Director | 30 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brinton Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.36% increase. The company also saw a slight decrease in profitability, with a 5.95% decrease in profit. The company's net worth Soared by an impressive increase of 22.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Brinton Pharmaceuticals had a promoter holding of 87.87% and a public holding of 12.13%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹752,500,000.00
₹815,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2025 | Others | ₹75.00 Cr | Open |
| 04 Aug 2020 | Others | ₹2.50 M | Open |
| 04 Sep 2024 | Others | ₹4.00 Cr | Satisfied |
| 27 Jun 2023 | Others | ₹7.50 Cr | Satisfied |
| 09 Jun 2023 | Others | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Brinton Pharmaceuticals has a workforce of 508 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Brinton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brinton Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 30 Aug 2021 via Charge ID 100514652 with Others was fully satisfied on 17 Apr 2025. was recorded as a recent event.
The activity A charge registered on 09 Jun 2023 via Charge ID 100730089 with Others was fully satisfied on 16 Apr 2025. was completed.
The activity A charge registered on 31 Jan 2023 via Charge ID 100673056 with Others was fully satisfied on 15 Apr 2025. was completed.
A charge registered on 04 Sep 2024 via Charge ID 100974582 with Others was fully satisfied on 05 Apr 2025. was recorded as a recent event.
A charge registered on 27 Jun 2023 via Charge ID 100750207 with Others was fully satisfied on 01 Apr 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101090172 was registered on 27 Mar 2025. was documented.
The company is on the road to raise further capital and has hired investment bank Citadel Securities to look for investors,” said one of the persons with direct knowledge of the companys plans..
India Business News: Mumbai, Nov 23 () Pune-based generic drug-maker Brinton Pharmaceuticals, which has raised USD 4 million from Tata Capital's healthcare-focused fund, i.
Investment by Tata Capital's healthcare fund will support Brinton Pharmaceutical's entry into newer areas such as paediatrics, gynaecology.
The CIN of Brinton Pharmaceuticals Limited is U24232PN2013PLC148971.
Brinton Pharmaceuticals Limited is headquartered at S. No 55/2 Kharadi, Taluka Haveli, Pune, Maharashtra, 411014.
Brinton Pharmaceuticals Limited was incorporated on 27 September 2013.
The current directors of Brinton Pharmaceuticals Limited are
The primary industry of Brinton Pharmaceuticals Limited is Trade.
Brinton Pharmaceuticals Limited is unlisted.
The authorized capital of Brinton Pharmaceuticals Limited is ₹2.00 Cr, and the paid-up capital is ₹1.09 Cr.
The compliance status of Brinton Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX